Convenient, with the most consistent (if modest) trial support, though absorption is debated and results are slower
By enhancing insulin function, reducing inflammation, and stabilizing glucose levels, GLP-1 antagonists may support long-term weight management and lower the risk of metabolic diseases like Type 2 diabetes and heart disease
Julie Cunningham, MPH, RDN, LDN, CDCES Medical Reviewer Julie Cunningham is a registered dietitian-nutritionist and a certified diabetes care and education specialist
Both medications carry a similar risk of gastrointestinal side effects, including constipation
Canada residents can call a provincial poison control center
doi: 10.1093/neuonc/noq080 124 LuanWWangYChenXShiYWangJZhangJet al